INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹241 Cr | ₹280 Cr | ₹23 Cr | ₹-44 Cr | ₹-30 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹-44 Cr |
| Mar2021 | ₹-30 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -13.91 | |
| Mar2024 | ₹280 Cr | 1,129.76 | |
| Mar2023 | ₹23 Cr | Positive | |
| Mar2022 | ₹-44 Cr | Negative | |
| Mar2021 | ₹-30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,855.2 Cr | -2.3% | -6.7% | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.3% |
-6.7% |
-9.9% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses